Jeffrey Johnson is a legal writer with a focus on personal injury. He has worked on personal injury and sovereign immunity litigation in addition to experience in family, estate, and criminal law. He earned a J.D. from the University of Baltimore and has worked in legal offices and non-profits in Maryland, Texas, and North Carolina. He has also earned an MFA in screenwriting from Chapman Univer...

Full Bio →

Written by

Jeffrey Johnson is a legal writer with a focus on personal injury. He has worked on personal injury and sovereign immunity litigation in addition to experience in family, estate, and criminal law. He earned a J.D. from the University of Baltimore and has worked in legal offices and non-profits in Maryland, Texas, and North Carolina. He has also earned an MFA in screenwriting from Chapman Univer...

Full Bio →

Reviewed by Jeffrey Johnson
Managing Editor & Insurance Lawyer

UPDATED: May 5, 2016

Advertiser Disclosure

It’s all about you. We want to help you make the right legal decisions.

We strive to help you make confident insurance and legal decisions. Finding trusted and reliable insurance quotes and legal advice should be easy. This doesn’t influence our content. Our opinions are our own.

Editorial Guidelines: We are a free online resource for anyone interested in learning more about legal topics and insurance. Our goal is to be an objective, third-party resource for everything legal and insurance related. We update our site regularly, and all content is reviewed by experts.

The link between shoulder pain pump medical devices and PAGCL, or Postarthroscopic Glenohumeral Chondrolysis – a condition in which cartilage degenerates between the bone and socket of the shoulder – has been fairly established in several studies. Even though that information is something legal experts say should benefit those who have been injured, the harsh reality of the situation is that injured victims continue to suffer – sometimes even more than before their surgeries and with little hope of rehabilitation.

Cartilage degeneration not new

While PAGCL may be a fairly new discovery, the idea of cartilage degeneration is not, according to Rhett Klok, a South Carolina attorney for over 15 years whose practice focuses in medical health litigation including medical devices, pharmaceuticals and medical malpractice. He explained:

The relationship of these anesthetics dissolving the cartilage, or potentially causing complete dissolution of the cartilage space between the bone and socket of your shoulder, is new to the general public. Although the relationship statistically seems to be inescapable based on the studies done, the mechanism of injury is probably something that’s still going to be studied and the relationship is still going to be looked at. I’m certain that there will be other articles that will come out as we move forward.

In the meantime, he says that shoulder injury patients continue to suffer.

Suffering likely to be worse than in preoperative condition

Klok told us that he believes that patients would have a manifestation of this problem up to eight months after surgery, but probably sometime before that – and that the pain they will suffer will likely be significantly worse than their preoperative condition. He says that, “X-rays will show dissolution of the shoulder space cartilage at the ball and joints area. PAGCL, or chondrolysis, are the words they’ll hear from their doctors and it will most likely fit the parameters of somebody who used a pain pump. They ought to consult with a lawyer and explore their options if they can.”